SPTLC1 variants associated with ALS produce distinct sphingolipid signatures through impaired interaction with ORMDL proteins
Museer A. Lone(University of Zurich), Thorsten Hornemann(University Hospital of Zurich)
Cited by 59
Related Papers
DEGS1-associated aberrant sphingolipid metabolism impairs nervous system function in humans
|Journal of Clinical Investigation|2019|129
ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma
|Cancer Research|2023|24
SPTLC1 variants associated with childhood onset amyotrophic lateral sclerosis produce distinct sphingolipid signatures through impaired interaction with ORMDL proteins
|bioRxiv (Cold Spring Harbor Laboratory)|2022|1